Accuray Technology and Product Pipeline 4494

This year's featured leaders illustrate medtech's ability to adapt and thrive in an ever-changing business environment.

Steve Halasey

September 1, 2008

1 Min Read
MDDI logo in a gray background | MDDI

COVER STORY

Return to article:

Focused for Growth

In 1987, after completing a fellowship in Sweden with Lars Leksell, MD, the founder of radiosurgery, John R. Adler, MD, a professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife robotic radiosurgery system. The goal of the CyberKnife system was to extend the benefits of radiosurgery to the treatment of tumors anywhere in the body by incorporating robotics and image guidance, and thereby eliminating the need for invasive stabilizing frames.

(click to enlarge)Accuray's Synchrony respiratory tracking system enables clinicians to continuously track, detect, and correct for tumors that are affected by respiration, while a patient is undergoing therapy.

In 1990, Accuray Inc. (Sunnyvale, CA) was founded.

In the years since, Accuray has continued to pursue advances in the field of radiosurgery. In 2004, the company received FDA clearance for its Synchrony respiratory tracking system. The Synchrony system enables clinicians to continuously track, detect, and correct for tumors that are affected by respiration, such as those in the lungs, liver, and pancreas, without breath-holding or gating techniques.

To date, more than 50,000 patients worldwide have undergone CyberKnife radiosurgery. Since the launch of the CyberKnife system, Accuray has undertaken an aggressive strategy to develop system upgrades that facilitate clinicians' ability to treat tumors anywhere in the body with high levels of accuracy.

Copyright ©2008 MX

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like